142 related articles for article (PubMed ID: 12791813)
1. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
[TBL] [Abstract][Full Text] [Related]
5. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.
Bax JJ; Visser FC; Poldermans D; Van Lingen A; Elhendy A; Boersma E; Sloof GW; Visser CA
J Nucl Cardiol; 2002; 9(6):587-93. PubMed ID: 12466782
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
8. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Schröder O; Hör G; Hertel A; Baum RP
Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and application of trimetazidine in
Shao X; Chen Y; Chen Y; Zhang F; Zhou M; Niu R; Wang Y
J Nucl Cardiol; 2022 Oct; 29(5):2497-2507. PubMed ID: 34331217
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
[TBL] [Abstract][Full Text] [Related]
11. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
13. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
[TBL] [Abstract][Full Text] [Related]
14. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
[TBL] [Abstract][Full Text] [Related]
15. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
16. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA; Mansour CS; Eisner RL; Churchwell KB; Williams BR; Sigman SR; Streeter J; Patterson RE
J Nucl Med; 2005 Oct; 46(10):1602-9. PubMed ID: 16204709
[TBL] [Abstract][Full Text] [Related]
17.
Mhlanga J; Derenoncourt P; Haq A; Bhandiwad A; Laforest R; Siegel BA; Dehdashti F; Gropler RJ; Schindler TH
J Nucl Med; 2022 Apr; 63(4):602-608. PubMed ID: 34503961
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.
Kluge R; Barthel H; Pankau H; Seese A; Schauer J; Wirtz H; Seyfarth HJ; Steinbach J; Sabri O; Winkler J
J Nucl Med; 2005 Jan; 46(1):25-31. PubMed ID: 15632029
[TBL] [Abstract][Full Text] [Related]
19. Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography.
Sloof GW; Knapp FF; van Lingen A; Eersels J; Poldermans D; Bax JJ
Nucl Med Commun; 2003 Apr; 24(4):375-81. PubMed ID: 12673165
[TBL] [Abstract][Full Text] [Related]
20. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
